Motility disorders of the colon and rectum

Current Opinion in Gastroenterology

Volumn 28, Issue 1, 2012, Pages 52-56

  Wald, Arnold ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Colonic motility; Constipation; Laxatives; Opioid induced constipation; Sacral neuromodulation

Indexed keywords

17 METHYLNALTREXONE; A 3309; BISACODYL; LAXATIVE; LUBIPROSTONE; OPIATE; PICOSULFATE SODIUM; PLACEBO; PRUCALOPRIDE; UNCLASSIFIED DRUG; VELUSETRAG;

ANORECTAL DISEASE; COLON MOTILITY; COLON RESECTION; CONSTIPATION; DIARRHEA; HEADACHE; HUMAN; ILEORECTAL ANASTOMOSIS; INTESTINAL DYSMOTILITY; NAUSEA AND VOMITING; PATHOGENESIS; RECTUM; RECTUM MOTILITY; REVIEW;

COLON; CONSTIPATION; DEFECATION; GASTROINTESTINAL MOTILITY; HUMANS; RECTUM;

EID: 84857043234     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e32834d4f61     Document Type: Review

References (26)

1. Metcalf AM, Phillips SF, Zinsmeister AR, et al. Simplified assessment of segmental colon transit. Gastroenterology 1987; 92:40-47. (Pubitemid 17207659)
2. Van der Sijp JR, Kamm MA, Nightingale JM, et al. Radioisotope determination of regional colonic transit in severe constipation: comparison with radioopaque markers. Gut 1993; 34:402-408. (Pubitemid 23080270)
3. Camilleri M, Thorne NK, Ringel Y, et al. Wireless pH-motility capsule for chronic transit: prospective comparison with radiopaque markers in chronic constipation. Neurogastro Motil 2010; 22:874-882.
4. Dinning PG, Zarate N, Hunt LM, et al. Pancolonic spectrotemporal mapping reveals regional deficiencies in, and disorganization of, colonic propagating pressure waves in severe constipation. Neurogastro Motil 2010; 22:e340-e349.
5. Dinning PG, Benninga MA, Southwell BR, Scott SM. Pediatric and adult colonic manometry: a tool to help unravel the pathophysiology of constipation. World J Gastro 2010; 16:5162-5172. This review critically examines the role of colonic manometry in current clinical practice in both adults and children with chronic constipation, its limitations and future applications.
6. Dinning PG, Di Lorenzo C. Colonic dysmotility in constipation. Best Pract Res Clin Gastroenterol 2011; 25:89-101.
7. Pensabene L, Yuossef NN, Griffiths JM, Di Lorenzo C. Colonic manometry in children with defecatory disorders: role in diagnosis and management. Am J Gastroenterol 2003; 98:1052-1057. (Pubitemid 36733766)
8. Meuller-Lissner S, Kamm MA, Wald A, et al. Multicenter, 4 week, double-blind, randomized, placebo-controlled trial of sodium picosulfate in patients with chronic constipation. Am J Gastroenterol 2010; 105:897-903.
9. Kamm MA, Muller-Lissner S, Wald A, et al. Oral bisacodyl is effective and well tolerated in patients with chronic constipation. Clin Gastro Hep 2011; 9:577-583. This recently published therapeutic trial counteracts the argument that there has been no evidence to support the use of this inexpensive and widely used laxative in chronic constipation.
10. Ford AC, Suares NC. Effect of laxatives and pharmacological therapies in chronic idiopathic constipation: a systematic review and meta-analysis. Gut 2011; 60:209-218. This is a comprehensive and up-to-date meta-analysis of the efficacy of various pharmacologic agents available to treat chronic constipation.
11. Barish CF, Drossman DA, Johanson JF, Ueno R. Efficacy and safety of lubiprostone in patients with chronic constipation. Dig Dis Sci 2010; 55:1090-1097.
12. Lembo AJ, Schneier HA, Shiff SJ, et al. Two randomized trials of linaclotide for chronic constipation. N Engl J Med 2011; 365:527-536.
13. Johnston JM, Kurtz CB, Macdougall JE, et al. Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with IBS with constipation. Gastroenterology 2010; 139:1877-1886.
14. Muller-Lissner S, Rykx A, Kersten R, Vandeplassche L. A double blind, placebo controlled study of prucalopride in elderly patients with chronic constipation. Neurogastro Motil 2010; 22:991-998.
15. Goldberg M, Li Y-P, Johanson JF, et al. Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT agonist with high intrinsic activity, in chronic idiopathic constipation: a 4 week randomized, double blind, placebo controlled, dose response study. Aliment Pharm Ther 2010; 32:1102-1112.
16. Simren M, Bajor A, Gillberg PG, et al. Randomized, clinical trial: the IIeal bile acid transporter inhibitor A3309 vs. placebo in patients with chronic idiopathic constipation: a double blind study. Aliment Pharm Ther 2011; 34:41-50. This is a companion study (with [17]) to support the efficacy of this novel class of drug to stimulate colon motility and secretion in patients with chronic constipation, with the added potential benefit of lowering cholesterol levels.
17. Chey WD, Camilleri M, Change L, et al. A randomized, placebo controlled phase IIb trial of A3309, a bile acid transporter inhibitor, for chronic idiopathic constipation. Am J Gastroenterol 2011. This is a companion study (with [16]) to support the efficacy of this novel class of drug to stimulate colon motility and secretion in patients with chronic constipation, with the added potential benefit of lowering cholesterol levels.
18. Kamm MA, Dudding TC, Melenhorst J, et al. Sacral nerve stimulation for intractable constipation. Gut 2010; 59:333-340. This nonsham controlled multicenter study potentially opens a new opportunity for the treatment of severe and intractable constipation, which is more comprehensively discussed in [19].
19. Van Wunnik BP, Baeten CG, Southwell BR. Neuromodulation for constipation: sacral and transcutaneous stimulation. Best Pract Res Clin Gastroenterol 2011; 25:181-191.
20. Camilleri M. Opioid induced constipation: challenges and therapeutic opportunities. Am J Gastroenterol 2011; 106:835-842. This is a well written review of the increasing frequency of opioid use for chronic pain, the clinical challenges of treating opioid-induced constipation and the active research to overcome bowel dysfunction in this growing population.
21. Michna E, Blonsky ER, Schulman S, et al. Subcutaneous methylnaltrexone for treatment of opioid-induced constipation in patients with chronic nonmalignant pain: a randomized, controlled study. J Pain 2011; 12:554-562.
22. Sloots CE, Rykx A, Cools M, et al. Efficacy and safety of prucalopride in patients with chronic, noncancer pain suffering from opioid induced constipation. Dig Dis Sci 2010; 55:2912-2921.
23. Rao SS. Biofeedback therapy for constipation in adults. Best Pract Res Clin Gastroenterol 2011; 25:159-166. A very nice review of this area by one of the more prolific investigators of anorectal dysfunctions.
24. Rao SS, Valestin J, Brown CK, et al. Long term efficacy of biofeedback therapy for dyssynergic defecation: randomized, controlled trial. Am J Gastroenterol 2010; 105:890-896.
25. Bharucha AE, Wald A, Enck P, Rao S. Functional disorders of the anus and rectum. Gastroenterol 2006; 130:1510-1518.
26. Chiarioni G, Nardo A, Vantini I, et al. Biofeedback is superior to electrogalvanic stimulation and massage for treatment of levator ani syndrome. Gastroenterology 2010; 138:1321-1329.